GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Centene Corp (NYSE:CNC) » Definitions » Ending Cash Position

Centene (Centene) Ending Cash Position : $17,452 Mil (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Centene Ending Cash Position?

Centene's Ending Cash Position for the quarter that ended in Dec. 2023 was $17,452 Mil.

Centene's quarterly Ending Cash Position increased from Jun. 2023 ($17,528 Mil) to Sep. 2023 ($18,450 Mil) but then declined from Sep. 2023 ($18,450 Mil) to Dec. 2023 ($17,452 Mil).

Centene's annual Ending Cash Position declined from Dec. 2021 ($13,214 Mil) to Dec. 2022 ($12,330 Mil) but then increased from Dec. 2022 ($12,330 Mil) to Dec. 2023 ($17,452 Mil).

Centene Ending Cash Position Historical Data

The historical data trend for Centene's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centene Ending Cash Position Chart

Centene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,131.00 10,957.00 13,214.00 12,330.00 17,452.00

Centene Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,330.00 16,165.00 17,528.00 18,450.00 17,452.00

Centene Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Centene's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=12280+5172
=17,452

Centene's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=18436+-984
=17,452

Centene Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Centene's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Centene (Centene) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Centene Corp (NYSE:CNC) » Definitions » Ending Cash Position
Comparable Companies
HUM MOH OSCR ALHC CLOV NEUE MRAI PFHO CVS CI UNH ELV SZSE:000503 BSP:ODPV3 NSE:MEDIASSIST BJSE:870656 BSP:QUAL3 ROCO:6665 MIL:HI TSXV:NXG
Traded in Other Exchanges
CNC:Mexico 1CNC:Italy QEN:Germany QEN:Germany C1NC34:Brazil
Address
7700 Forsyth Boulevard, Centene Plaza, St. Louis, MO, USA, 63105
Website
https://www.centene.com
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.
Executives
Lori Jean Robinson director 5875 LANDERBROOK DRIVE, SUITE 220, CLEVELAND OH 44124
Andrew Lynn Asher officer: EVP, CFO 8735 HENDERSON ROAD, TAMPA FL 33634
James E Murray officer: EVP, Chief Transform. Officer 500 WEST MAIN STREET, LOUISVILLE KY 40202
Samuels Theodore R. Ii director 1990 E. GRAND AVE., EL SEGUNDO CA 90245
Monte E Ford director C/O AKAMAI TECHNOLOGIES, INC., 8 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Kenneth J Fasola officer: EVP, Health Care Enterprises 500 WEST MAIN STREET, LOUISVILLE KY 40202
Shannon Bagley officer: EVP, Chief Admin. Officer 7700 FORSYTH BOULEVARD, CLAYTON MO 63105
Richard A Gephardt director 822 CAPITOL SQUARE PLACE, SW, WASHINGTON DC 20024
Christopher J Coughlin director
H James Dallas director 127 PUBLIC SQUARE, CLEVELAND OH 44114
Mark J Brooks officer: SVP, Chief Information Officer 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
David P Thomas officer: EVP, MARKETS 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
Leslie V Norwalk director C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Wayne S Deveydt director 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Toney Colin A officer: EVP, Mergers & Acquisitions 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105